Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.22.9781

May the Platelet to Lymphocyte Ratio be a Prognostic Factor for Epithelial Ovarian Cancer?  

Kokcu, Arif (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Kurtoglu, Emel (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Celik, Handan (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Tosun, Migraci (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Malatyalıoglu, Erdal (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Ozdemir, Ayse Zehra (Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ondokuz Mayis)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.22, 2014 , pp. 9781-9784 More about this Journal
Abstract
Background: The study aimed to evaluate changes in hematologic parameters, including white blood cell, platelet count, platelet indices, the platelet to lymphocyte and neutrophil to lymphocyte ratios in patients with early and advanced stages of epithelial ovarian cancers. Materials and Methods: The study included 100 patients with epithelial ovarian cancer who underwent primary staging exploratory laparotomy. Preoperative hematologic parameters, tumor histopathologic type, grade, stage and serum CA-125 levels were retrospectively analyzed. These parameters were compared between the patients with early (stage I-II) and advanced (stage III-IV) ovarian cancer. Results: White blood cell count and platelet indices, including mean platelet volume, platelet distribution width and platelet crit did not show a statistically significant difference between groups with early and advanced ovarian cancer. However, the neutrophil to lymphocyte ratio, platelet count, the platelet to lymphocyte ratio and CA-125 level showed a statistically significant difference between the two groups (p<0.05, p<0.01, p<0.001, p<0.01 respectively). Conclusions: It was found that the neutrophil to lymphocyte ratio, platelet count and the platelet to lymphocyte ratio increased with the increasing stage of ovarian cancer. Furthermore, it was seen that the platelet to lymphocyte ratio is an independent prognostic factor related to the stage of epithelial ovarian cancer.
Keywords
Epithelial ovarian cancer; neutrophil to lymphocyte ratio; prognostic factor;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Acmaz G, Aksoy H, Unal D, et al (2014). Are neutrophil/ lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev, 15, 1689-92.   과학기술학회마을   DOI
2 Asher V, Lee J, Innamaa A, Bali A (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503.   DOI   ScienceOn
3 Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet, 357, 539-45.   DOI   ScienceOn
4 Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23.   DOI   ScienceOn
5 Cho MS, Bottsford-Miller J, Vasquez HG, et al (2012). Platelets increase the proliferation of ovarian cancer cells. Blood, 120, 4869-72.   DOI   ScienceOn
6 Crasta JA, Premlatha TS, Krishnan SM, Vallikad E, Rameshkumar K (2010). Significance of preoperative thrombocytosis in epithelial ovarian cancer. Indian J Pathol Microbiol, 53, 54-6.   DOI
7 Dirican A, Kucukzeybek Y, Erten C, et al (2013). Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alpha. Asian Pac J Cancer Prev, 14, 2101-5.   과학기술학회마을   DOI   ScienceOn
8 Feng JF, Huang Y, Chen QX (2014). Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol, 12, 58.   DOI
9 Ikeda M, Furukawa H, Imamura H, et al (2002). Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol, 9, 287-91.   DOI   ScienceOn
10 Karpatkin S, Pearlstein E (1981). Role of platelets in tumor cell metastases. Ann Intern Med, 95, 636-41.   DOI   ScienceOn
11 Kemal Y, Yucel I, Ekiz K, et al (2014). Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pac J Cancer Prev, 15, 2651-4.   과학기술학회마을   DOI   ScienceOn
12 Lee M, Kim SW, Nam EJ, et al (2011). The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 122, 238-41.   DOI   ScienceOn
13 Li AJ, Madden AC, Cass I, et al (2004). The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol, 92, 211-4.   DOI   ScienceOn
14 Ma X, Wang Y, Sheng H, et al (2014). Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer. J Obstet Gynaecol Res, 40, 178-83.   DOI
15 Mallappa S, Sinha A, Gupta S, Chadwick SJ (2013). Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis, 15, 323-8.   DOI
16 Roxburgh CS, McMillan DC (2010). Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol, 6, 149-63.   DOI   ScienceOn
17 Miglani RK, Bhateja N, Bhat RS, Kumar KV (2013). Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in pancreatic head masses. Indian J Surg, 75, 4-9.   DOI
18 O'Keefe SC, Marshall FF, Issa MM, Harmon MP, Petros JA (2002). Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol, 168, 1378-80.   DOI
19 Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012). Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol, 23, 265-73.   DOI
20 Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8.   DOI   ScienceOn
21 Suh DH, Kim HS, Chung HH, et al (2012). Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. Eur J Obstet Gynecol Reprod Biol, 162, 206-10.   DOI
22 Tamussino KF, Gucer F, Reich O, et al (2001). Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer, 11, 236-40.   DOI   ScienceOn
23 Tanoglu A, Yiyit N, Berber U, Karagoz E (2014). Is the combination of neutrophil to lymphocyte and platelet to lymphocyte ratios a useful predictor of treatment response and prognosis in patients with non-small cell lung cancer? Asian Pac J Cancer Prev, 15, 4373.   과학기술학회마을   DOI
24 Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.   과학기술학회마을   DOI   ScienceOn
25 Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7.
26 Topcu HO, Guzel AI, Ozer I, et al (2014). Comparison of neutrophil/lymphocyte and platelet/ lymphocyte ratios for predicting malignant potential of suspicious ovarian masses in gynecology practice. Asian Pac J Cancer Prev, 15, 6239-41.   과학기술학회마을   DOI
27 Tuszynski GP, Nicosia RF (1996). The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays, 18, 71-6.   DOI
28 Vergote IB, Kaern J, Abeler VM, et al (1993). Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol, 169, 40-52.   DOI   ScienceOn
29 Williams KA, Labidi-Galy SI, Terry KL, et al (2014). Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol Oncol, 132, 542-50.   DOI
30 Zeimet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O (1994). Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol, 170, 549-54.   DOI   ScienceOn